Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.

Neishabury M, Zamani F, Keyhani E, Azarkeivan A, Abedini SS, Eslami MS, Kakroodi ST, Vesiehsari MJ, Najmabadi H.

Blood Cells Mol Dis. 2013 Aug;51(2):80-4. doi: 10.1016/j.bcmd.2013.02.007. Epub 2013 Mar 28.

PMID:
23541515
2.

The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5'HS4.

Neishabury M, Zamani S, Azarkeivan A, Abedini SS, Darvish H, Zamani F, Najmabadi H.

Blood Cells Mol Dis. 2012 Jan 15;48(1):1-5. doi: 10.1016/j.bcmd.2011.10.001. Epub 2011 Oct 28.

PMID:
22036762
3.

Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.

Neishabury M, Azarkeivan A, Oberkanins C, Abedini SS, Zamani S, Najmabadi H.

Blood Cells Mol Dis. 2011 Mar 15;46(3):201-5. doi: 10.1016/j.bcmd.2010.12.007. Epub 2011 Jan 12.

PMID:
21232998
4.

The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.

Keyhani E, Jafari Vesiehsari M, Talebi Kakroodi S, Darabi E, Zamani F, Karimlou M, Kamali K, Neishabury M.

Hemoglobin. 2016 Jun;40(3):198-201. doi: 10.3109/03630269.2016.1160920.

PMID:
27117569
5.

Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.

Pereira C, Relvas L, Bento C, Abade A, Ribeiro ML, Manco L.

Blood Cells Mol Dis. 2015 Apr;54(4):315-20. doi: 10.1016/j.bcmd.2015.02.001. Epub 2015 Feb 21.

PMID:
25842369
6.

The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.

Nguyen TK, Joly P, Bardel C, Moulsma M, Bonello-Palot N, Francina A.

Blood Cells Mol Dis. 2010 Aug 15;45(2):124-7. doi: 10.1016/j.bcmd.2010.04.002. Epub 2010 May 15.

PMID:
20472475
7.

Electromobility Shift Assay Reveals Evidence in Favor of Allele-Specific Binding of RUNX1 to the 5' Hypersensitive Site 4-Locus Control Region.

Dehghani H, Ghobakhloo S, Neishabury M.

Hemoglobin. 2016 Aug;40(4):236-9. doi: 10.1080/03630269.2016.1189931.

PMID:
27492765
8.

Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.

Rujito L, Basalamah M, Siswandari W, Setyono J, Wulandari G, Mulatsih S, Sofro AS, Sadewa AH, Sutaryo S.

Hematol Oncol Stem Cell Ther. 2016 Jun;9(2):55-63. doi: 10.1016/j.hemonc.2016.02.003. Epub 2016 Mar 17.

9.

[Correlation between hemoglobin F levels and single nucleotide polymorphism at BCL11A gene rs11886868 locus in β-thalassemia patients].

Chen QR, Sun SC, Peng YS, Wang Q, Mo BM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):650-3. Chinese.

PMID:
22739175
10.

Phenotypic expression of Hb F in common high Hb F determinants in Thailand: roles of α-thalassemia, 5' δ-globin BCL11A binding region and 3' β-globin enhancer.

Prakobkaew N, Fucharoen S, Fuchareon G, Siriratmanawong N.

Eur J Haematol. 2014 Jan;92(1):73-9. doi: 10.1111/ejh.12201. Epub 2013 Oct 24.

PMID:
24112054
11.

Microsatellite and single nucleotide polymorphisms in the β-globin locus control region-hypersensitive Site 2: SPECIFICITY of Tunisian βs chromosomes.

Ben Mustapha M, Moumni I, Zorai A, Douzi K, Ghanem A, Abbes S.

Hemoglobin. 2012;36(6):533-44. doi: 10.3109/03630269.2012.721432. Epub 2012 Oct 29.

PMID:
23101664
12.

Amelioration of Sardinian beta0 thalassemia by genetic modifiers.

Galanello R, Sanna S, Perseu L, Sollaino MC, Satta S, Lai ME, Barella S, Uda M, Usala G, Abecasis GR, Cao A.

Blood. 2009 Oct 29;114(18):3935-7. doi: 10.1182/blood-2009-04-217901. Epub 2009 Aug 20.

13.

Influences of genetic variation on fetal hemoglobin.

He Y, Lin W, Luo J.

Pediatr Hematol Oncol. 2011 Nov;28(8):708-17. doi: 10.3109/08880018.2011.616573.

PMID:
22023465
14.

Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.

Pakdee N, Yamsri S, Fucharoen G, Sanchaisuriya K, Pissard S, Fucharoen S.

Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):11-5. doi: 10.1016/j.bcmd.2014.02.005. Epub 2014 Feb 26.

PMID:
24581976
15.
16.

Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia.

Ma Q, Abel K, Sripichai O, Whitacre J, Angkachatchai V, Makarasara W, Winichagoon P, Fucharoen S, Braun A, Farrer LA.

Clin Genet. 2007 Dec;72(6):497-505. Epub 2007 Sep 25.

PMID:
17894837
17.

Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.

Buccheri MA, Spina S, Ruberto C, Lombardo T, Labie D, Ragusa AA.

Hemoglobin. 2013;37(5):423-34. doi: 10.3109/03630269.2013.800823. Epub 2013 Jun 19.

PMID:
23777413
18.

Transcriptional silencing of fetal hemoglobin by BCL11A.

Sankaran VG, Xu J, Orkin SH.

Ann N Y Acad Sci. 2010 Aug;1202:64-8. doi: 10.1111/j.1749-6632.2010.05574.x.

PMID:
20712774
19.

Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.

Danjou F, Anni F, Perseu L, Satta S, Dessì C, Lai ME, Fortina P, Devoto M, Galanello R.

Haematologica. 2012 Jul;97(7):989-93. doi: 10.3324/haematol.2011.053504. Epub 2012 Jan 22.

20.

Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.

Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, Mikkola HK, Hirschhorn JN, Cantor AB, Orkin SH.

Science. 2008 Dec 19;322(5909):1839-42. doi: 10.1126/science.1165409. Epub 2008 Dec 4.

Supplemental Content

Support Center